T Cell News and Research

Latest T Cell News and Research

Researchers develop 'Trojan horse' approach to destroy cancer cells

Cancer cells are killed in lab experiments and tumour growth reduced in mice, using a new approach that turns a nanoparticle into a 'Trojan horse' that causes cancer cells to self-destruct, a research team at the Nanyang Technological University, Singapore (NTU Singapore) has found.

23 Sep 2020

New T-cell-based vaccine strategy provides broader protection against seasonal influenza

As Americans begin pulling up their sleeves for an annual flu vaccine, researchers at the University of Wisconsin-Madison have provided new insights into an alternative vaccine approach that provides broader protection against seasonal influenza.

23 Sep 2020

Chaperone-mediated autophagy could be a new therapeutic target for spinocerebellar ataxia

A research team from Kumamoto University, Japan has developed an animal model that reproduces motor dysfunction and cerebellar neurodegeneration similar to that in spinocerebellar ataxia (SCA) by inhibiting chaperone-mediated autophagy (CMA) in cerebellar neurons.

23 Sep 2020

No discernable difference in SARS-CoV-2 viral loads of young children versus older children and adults

Sharline Madera et al. , in a recent medRxiv* preprint paper, show a detailed investigation of viral nucleic acid among young children and adults, involving over 5,000 cases confirmed by RT-PCR (Reverse Transcriptase – Polymerase Chain Reaction) assay.

23 Sep 2020

Bat and pangolin coronavirus structure sheds light on SARS-CoV-2 evolution

Researchers at Tsinghua University, Beijing, have conducted a study providing possible new insights into the evolution and cross-species transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

23 Sep 2020

Drugs used to treat HIV and hepatitis B could be repurposed to prevent type 2 diabetes

A group of drugs used to treat HIV and hepatitis B could be repurposed to prevent type 2 diabetes, a new study suggests.

23 Sep 2020

'Silent' wave of neurological consequences may be on its way due to COVID-19

Is the world prepared a wave of neurological consequences that may be on its way as a result of COVID-19? This question is at the forefront of research underway at the Florey Institute of Neuroscience and Mental Health.

23 Sep 2020

OXGENE launches a scalable, plasmid-free manufacturing system for AAV

OXGENE™, a biotechnology company designing and developing scalable gene therapy technologies, has today announced the launch of its scalable, plasmid-free manufacturing system for AAV.

From OXGENE 23 Sep 2020

Cephalopod + Tomocube = New formula for molecular probes

Researchers have discovered how to use the cephalopod proteins responsible for these changes to manipulate the optical RI of mammalian compartments.

From Tomocube Inc. 23 Sep 2020

HIV drugs cause immune-system changes that can improve resistance to viral infections

Drugs currently used to keep the HIV virus in check also cause immune-system changes that might make humans better able to resist viral infections – but might also cause harmful inflammation, according to a study published today in Cell Reports Medicine.

23 Sep 2020

New book sheds light on addiction to psychoactive drugs

Cold Spring Harbor Laboratory Press (CSHLP) announced the publication of Addiction, 2e, now available on its website in ebook and hardcover formats.

23 Sep 2020

Children exhibit distinct immune system responses against COVID-19

Children and adults exhibit distinct immune system responses to infection by the virus that causes COVID-19, a finding that helps explain why COVID-19 outcomes tend to be much worse in adults, researchers from Yale and Albert Einstein College of Medicine report Sept. 18 in the journal Science Translational Medicine.

23 Sep 2020

New technique helps visualize the mechanical forces of cells at the molecular level

Scientists have developed a new technique using tools made of luminescent DNA, lit up like fireflies, to visualize the mechanical forces of cells at the molecular level.

23 Sep 2020

A subunit SARS-CoV-2 vaccine may offer broader protection against virus

A new study published in the preprint server bioRxiv in September 2020 reports on the structure of this protein, as revealed by cryo-electron microscopy (cryoEM).

23 Sep 2020

Molecular dynamic simulations reveal detailed spike-ACE2 interactions

The current COVID-19 pandemic has spread throughout the world. Caused by a single-stranded RNA betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is closely related to but much more infectious than the earlier highly pathogenic betacoronaviruses SARS and MERS-CoV, has impacted social, economic, and physical health to an unimaginable extent.

23 Sep 2020

Common genetic variants may influence susceptibility to COVID-19

Researchers in the United States and Japan have conducted a study suggesting that a commonly occurring genetic variant influences susceptibility to infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the agent that causes coronavirus disease 2019 (COVID-19).

23 Sep 2020

Study suggests herd immunity to COVID-19 in Brazilian city of Manaus

According to the study estimates, the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes COVID-19 – rapidly increased in Manaus between March and April, before slowly declining between May and September.

22 Sep 2020

Baseline T cell signatures predict clinical outcomes of SARS-CoV infection

In a recent bioRxiv preprint paper, researchers from the Department of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, OR, and Department of Global Health, University of Washington, Seattle, WA, discuss their study in mice that undergo detailed immunophenotyping before getting infected with SARS-CoV.

22 Sep 2020

Acquisition of a natural mutation primes SARS-CoV-2 for neutralization by a cross-reactive antibody

A team of scientists from the United States reveals that the acquisition of a natural mutation makes severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) susceptible to neutralization by a cross-reactive SARS-CoV antibody. The study is currently available on the bioRxiv* preprint server.

22 Sep 2020

Targeted treatment for systemic lupus erythematosus

A team of researchers from Charité - Universitätsmedizin Berlin and the Deutsches Rheuma-Forschungszentrum Berlin, a Leibniz Institute, have successfully treated two patients with the autoimmune disease systemic lupus erythematosus.

22 Sep 2020

T Cell News and Research

Latest T Cell News and Research

Researchers develop 'Trojan horse' approach to destroy cancer cells

New T-cell-based vaccine strategy provides broader protection against seasonal influenza

Chaperone-mediated autophagy could be a new therapeutic target for spinocerebellar ataxia

No discernable difference in SARS-CoV-2 viral loads of young children versus older children and adults

Bat and pangolin coronavirus structure sheds light on SARS-CoV-2 evolution

Drugs used to treat HIV and hepatitis B could be repurposed to prevent type 2 diabetes

'Silent' wave of neurological consequences may be on its way due to COVID-19

OXGENE launches a scalable, plasmid-free manufacturing system for AAV

Cephalopod + Tomocube = New formula for molecular probes

HIV drugs cause immune-system changes that can improve resistance to viral infections

New book sheds light on addiction to psychoactive drugs

Children exhibit distinct immune system responses against COVID-19

New technique helps visualize the mechanical forces of cells at the molecular level

A subunit SARS-CoV-2 vaccine may offer broader protection against virus

Molecular dynamic simulations reveal detailed spike-ACE2 interactions

Common genetic variants may influence susceptibility to COVID-19

Study suggests herd immunity to COVID-19 in Brazilian city of Manaus

Baseline T cell signatures predict clinical outcomes of SARS-CoV infection

Acquisition of a natural mutation primes SARS-CoV-2 for neutralization by a cross-reactive antibody

Targeted treatment for systemic lupus erythematosus

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in